Diseases, Conditions, Syndromes

The dark side of treating COVID-19 with monoclonal antibodies

A recent study conducted as part of the ORCHESTRA project has shed new light on the treatment of COVID-19 infections with mAbs. Published in the Journal of Clinical Investigation, the research reveals that patients treated ...

Medications

Regenerative drug restores bone in preclinical study

Bone loss is a part of aging that compromises quality of life and movement in many older people, but regenerative treatments to improve their health and well-being have been limited. Now, a study led by Lankenau Institute ...

Oncology & Cancer

Researchers expanding the types of cancer CAR-T therapy can target

Teaching the body's immune cells to recognize and fight cancer is one of the holy grails in medicine. Over the past two decades, researchers have developed new immunotherapy drugs that stimulate a patient's immune cells to ...

Oncology & Cancer

New genetic culprit suspected in the onset of pancreatic cancer

New research out of VCU Massey Cancer Center points to the inactivation of a previously unidentified gene as a likely culprit in the development of pancreatic cancer. Recently published in Cell Reports, the findings could ...

Medical research

Old mice regain leg strength after antibody treatment

Muscle stem cells, the cells in muscle fibers that generate new muscle cells after injury or exercise, lose their potency with age. But a study by researchers at Stanford Medicine shows that old mice regain the leg muscle ...

Medications

Anti-diarrhea medication may help treat core autism symptoms

There are currently no effective treatments for the core symptoms of autism spectrum disorder (ASD), such as difficulties with socializing and communicating. A new study uses a computer-based protein interaction network to ...

page 3 from 17